“Early Phase I Results for 4-Demethyl-4-cholesteryloxypenclo-medine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies ” (2018) Journal of Cancer Research Updates, 7(3), pp. 75–78. doi:10.6000/1929-2279.2018.07.03.2.